Login / Signup

Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based Study.

Niels A D GuchelaarBo J NoordmanMarion W WeltenMyron T van SantenMicha J de NeijsStijn L W KoolenRob H A VerhoevenEsther Oomen-de HoopPieter C van der SluisSjoerd M LagardeHanneke W M van LaarhovenIgnace H J T de HinghGeert-Jan CreemersBianca MostertBas P L WijnhovenRon H J Mathijssen
Published in: Journal of the National Comprehensive Cancer Network : JNCCN (2024)
There is substantial heterogeneity in systemic treatment choices in patients with gastric cancer and peritoneal metastases in the Netherlands. In this study, patients treated with triplets containing docetaxel and with trastuzumab-containing regimens survived longer than patients who received doublet therapy. Despite this, median OS for all treatment groups remained below one year.
Keyphrases
  • stem cells
  • single cell
  • epidermal growth factor receptor
  • type diabetes
  • radiation therapy
  • replacement therapy
  • mesenchymal stem cells
  • bone marrow
  • locally advanced
  • rectal cancer